Cardiovascular patients were slightly older than controls, had a higher proportion of smokers, had more comorbidities such as arterial hypertension, dyslipidemia, and diabetes mellitus, and were mostly on medication such as antiplatelet treatment, statins, angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker, and β‐blocker. Here, ACE is linked to metabolic syndrome.